A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

Further, in Diabetes, Medtronic’s MiniMed 780G system recently gained a CE Mark for use with the Simplera Sync sensor and is expected for FDA submission in the first half of this calendar year.